On August 16, 2022, the Ontario Court of Appeal (ONCA) released its decision in Apotex Inc. v. Eli Lilly Canada Inc., 2022 ONCA 587. The ONCA denied Apotex’s appeal of a lower court summary judgement decision that dismissed Apotex’s novel claims under the UK and Ontario Statutes of Monopolies, the Trademarks Act, and at common law
Latest Post
More Posts
Federal Court of Appeal Gradually Phases Out Suspension Period
Federal Court of Appeal Restores Suspension Period
G.I. Joe et le marquage de produits brevetés
Federal Courts update guidance on COVID-19
Nouveaux incitatifs fiscaux en matière de propriété intellectuelle
Federal Courts begin to phase out the Suspension Period
Federal Courts Extend Suspension Periods to June 15
Quebec maintains drug evaluation activities for listing purposes and launches clinical trials
Confusion : bien plus que la somme de ses parties
Subscribe: Subscribe via RSS
Firm/Org